Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bennett: Estimates of the cost-effectiveness of a single course of interferon-α2b in patients.... (0.14 sec) 

Estimates of the cost-effectiveness of a single course of interferon-α2b in patients …


WG Bennett, Y Inoue, JR Beck, JB Wong, … - Annals of internal …, 1997 - Am Coll Physicians
For author affiliations and current author addresses, see end of text. From the University of Florida
College of Medicine, Gainesville, Florida; Baylor College of Medicine, Houston, Texas; Yamaguchi
University School of Medicine, Ube, Yamaguchi, Japan; and New England Medical ...
Cited by 220 - Related articles - BL Direct - All 6 versions

Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis …


W Kim, JJ Poterucha, JE Hermans, TM … - Annals of internal …, 1997 - Am Coll Physicians
Background: Interferon-α is effective in only a small number of patients with chronic hepatitis
C, although prolonged treatment may increase the response rate. There is concern that the expense
of interferon-α therapy may not be justified by the low response rates and uncertain long- ...
Cited by 125 - Related articles - BL Direct - All 5 versions

Cost effectiveness of interferon 2b combined with ribavirin for the treatment of …


ZM Younossi, ME Singer, JG McHutchison, KM … - Hepatology, 1999 - interscience.wiley.com
Treatment of chronic hepatitis C with Interferon (IFN) 2b monotherapy results in 10% to 15%
sustained virological response (SVR). Combining IFN with ribavirin increases this response.
In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C ( ...
Cited by 125 - Related articles - BL Direct - All 4 versions

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs


JB Wong, WG Bennett, RS Koff, SG Pauker - Jama, 1998 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context.— Chronic hepatitis C (CHC) infection ...
Cited by 148 - Related articles - BL Direct - All 6 versions

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving …

- googlepages.com [PDF] 
JA Salomon, MC Weinstein, JK Hammitt, SJ Goldie - Jama, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Approximately 2.7 million US individuals ...
Cited by 120 - Related articles - BL Direct - All 16 versions

Cost-effectiveness of 24 or 48 weeks of interferon a-2b alone or with ribavirin as …


JB Wong, T Poynard, MH Ling, JK Albrecht, SG … - Am J …, 2000 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 73 - Related articles - BL Direct - All 7 versions

Cost-effectiveness of combination therapy for naīve patients with chronic hepatitis …


M Buti, MA Casado, L Fosbrook, JB Wong, R Esteban - Journal of hepatology, 2000 - Elsevier
Background/Aims: The higher initial cost of combination therapy is a factor which may discourage
its use in naïve patients with histologically mild or moderate chronic hepatitis C. However, chronic
hepatitis C is a slowly progressive disease associated with a decrease in life expectancy ...
Cited by 54 - Related articles - BL Direct - All 8 versions

Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for …


K Sennfält, O Reichard, R Hultkrantz, JB … - Scandinavian …, 2001 - informahealthcare.com
Cost-effectiveness of Interferon Alfa-2b With and Without Ribavirin as ... Therapy for Chronic
Hepatitis C in Sweden ... K. Sennfält, O. Reichard, R. Hultkrantz, JB Wong & D. Jonsson Center
for Medical Technology Assessment, University of Linköping, Sweden; Depts. of ...
Cited by 24 - Related articles - BL Direct - All 7 versions

Cost effectiveness of combination therapy for hepatitis C: a decision analytic model

- bmj.com
K Stein, W Rosenberg, J Wong - British Medical Journal, 2002 - gut.bmj.com
Objective: To estimate the cost utility of treatment with combination therapy (ribavirin and interferon
) for hepatitis C compared with no treatment or monotherapy (interferon ) based on UK costs
and clinical management. ... Design: Decision analysis model using a Markov approach ...
Cited by 35 - Related articles - BL Direct - All 7 versions

Treatment of chronic type B and C hepatitis with interferon alfa: an economic …


GM Dusheiko, JA Roberts - Hepatology, 1995 - interscience.wiley.com
The aim of this study is to assess the long-term economic impact of treatment of chronic hepatitis
B and C with interferon alfa. Estimates were made of the progression of the disease over a
30-year period using a transitional probability model. Cohorts of 1,000 hypothetical ...
Cited by 120 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google